BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 31923639)

  • 1. Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection.
    Cheng YW; Phelps E; Nemes S; Rogers N; Sagi S; Bohm M; El-Halabi M; Allegretti JR; Kassam Z; Xu H; Fischer M
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2234-2243.e1. PubMed ID: 31923639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
    Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM
    Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Microbiota Transplantation for Severe or Fulminant
    Song YN; Yang DY; Veldhuyzen van Zanten S; Wong K; McArthur E; Song CZ; Ianiro G; Cammarota G; Kelly C; Fischer M; Russell L; Kao D
    J Can Assoc Gastroenterol; 2022 Feb; 5(1):e1-e11. PubMed ID: 35118227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with
    Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH
    Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.
    Cheng YW; Alhaffar D; Saha S; Khanna S; Bohm M; Phelps E; Ghabril M; Orman E; Sashidhar S; Rogers N; Xu H; Khoruts A; Vaughn B; Kao D; Wong K; Cammarota G; Ianiro G; Dhere T; Kraft CS; Mehta N; Woodworth MH; Allegretti JR; Nativ L; Marcus J; El-Nachef N; Fischer M
    Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1627-1634. PubMed ID: 32645451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical management of severe, fulminant, and refractory
    Cheng YW; Fischer M
    Expert Rev Anti Infect Ther; 2020 Apr; 18(4):323-333. PubMed ID: 32057278
    [No Abstract]   [Full Text] [Related]  

  • 7. A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory
    Monaghan TM; Duggal NA; Rosati E; Griffin R; Hughes J; Roach B; Yang DY; Wang C; Wong K; Saxinger L; Pučić-Baković M; Vučković F; Klicek F; Lauc G; Tighe P; Mullish BH; Blanco JM; McDonald JAK; Marchesi JR; Xue N; Dottorini T; Acharjee A; Franke A; Li Y; Wong GK; Polytarchou C; Yau TO; Christodoulou N; Hatziapostolou M; Wang M; Russell LA; Kao DH
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal microbiota transplantation may reduce the mortality of patients with severe and fulminant Clostridioides difficile infection compared to standard-of-care antibiotics in a community hospital.
    Mironova M; Ehrlich AC; Grinspan A; Protano MA
    J Dig Dis; 2022 Aug; 23(8-9):500-505. PubMed ID: 36183340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Faecal microbiota transplantation for Clostridioides difficile infection].
    Waldbaum C; López F; Antelo P; Sorda J
    Medicina (B Aires); 2020; 80(6):633-639. PubMed ID: 33254107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Luo Y; Tixier EN; Grinspan AM
    Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Microbiota Transplantation for Fulminant Clostridioides Difficile Infection: A Combined Medical and Surgical Case Series.
    Spartz EJ; Estafanos M; Mallick R; Gaertner W; Vakayil V; Jahansouz C; Aggarwal R; Ikramuddin S; Khoruts A; Harmon JV
    Cureus; 2023 Feb; 15(2):e34998. PubMed ID: 36938160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis.
    Cappetto CM
    Am J Health Syst Pharm; 2021 Jul; 78(15):1374-1381. PubMed ID: 33851215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Tariq R; Saha S; Solanky D; Pardi DS; Khanna S
    J Clin Gastroenterol; 2021 Jul; 55(6):542-547. PubMed ID: 32701563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.
    Hirten RP; Grinspan A; Fu SC; Luo Y; Suarez-Farinas M; Rowland J; Contijoch EJ; Mogno I; Yang N; Luong T; Labrias PR; Peter I; Cho JH; Sands BE; Colombel JF; Faith JJ; Clemente JC
    Inflamm Bowel Dis; 2019 May; 25(6):969-979. PubMed ID: 30852592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalized Older Patients with
    Shin JH; Hays RA; Warren CA
    Adv Geriatr Med Res; 2021; 3(2):. PubMed ID: 34263258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection.
    Saha S; Mara K; Pardi DS; Khanna S
    Clin Infect Dis; 2021 Oct; 73(7):e1706-e1712. PubMed ID: 32976567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.
    Cheng YW; Phelps E; Ganapini V; Khan N; Ouyang F; Xu H; Khanna S; Tariq R; Friedman-Moraco RJ; Woodworth MH; Dhere T; Kraft CS; Kao D; Smith J; Le L; El-Nachef N; Kaur N; Kowsika S; Ehrlich A; Smith M; Safdar N; Misch EA; Allegretti JR; Flynn A; Kassam Z; Sharfuddin A; Vuppalanchi R; Fischer M
    Am J Transplant; 2019 Feb; 19(2):501-511. PubMed ID: 30085388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes after faecal microbiota transplant by retention enema in both immunocompetent and immunocompromised patients with recurrent Clostridioides difficile infections at an academic medical centre.
    Navalkele BD; Polistico J; Sandhu A; Awali R; Krishna A; Chandramohan S; Tillotson G; Chopra T
    J Hosp Infect; 2020 Dec; 106(4):643-648. PubMed ID: 32991940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised Cohort.
    Suchman K; Luo Y; Grinspan A
    Dig Dis Sci; 2022 Oct; 67(10):4866-4873. PubMed ID: 35000023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement.
    Chauhan A; Apostolov R; van Langenberg D; Garg M
    Intern Med J; 2021 Jan; 51(1):106-110. PubMed ID: 33572016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.